Vontobel Holding Ltd. Has $7.72 Million Stake in Corteva, Inc. (NYSE:CTVA)

Vontobel Holding Ltd. lowered its stake in Corteva, Inc. (NYSE:CTVA - Free Report) by 3.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 135,497 shares of the company's stock after selling 4,410 shares during the quarter. Vontobel Holding Ltd.'s holdings in Corteva were worth $7,718,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of the stock. State Street Corp increased its holdings in Corteva by 2.3% during the third quarter. State Street Corp now owns 34,290,086 shares of the company's stock worth $2,015,914,000 after buying an additional 768,519 shares during the last quarter. Geode Capital Management LLC increased its holdings in Corteva by 2.0% during the third quarter. Geode Capital Management LLC now owns 17,703,771 shares of the company's stock worth $1,037,505,000 after buying an additional 355,206 shares during the last quarter. Franklin Resources Inc. increased its holdings in Corteva by 6.1% during the third quarter. Franklin Resources Inc. now owns 14,788,607 shares of the company's stock worth $860,746,000 after buying an additional 856,007 shares during the last quarter. Harris Associates L P increased its holdings in Corteva by 1.4% during the third quarter. Harris Associates L P now owns 14,362,309 shares of the company's stock worth $844,360,000 after buying an additional 200,917 shares during the last quarter. Finally, FMR LLC increased its holdings in Corteva by 1.9% during the third quarter. FMR LLC now owns 10,747,791 shares of the company's stock worth $631,863,000 after buying an additional 203,126 shares during the last quarter. Institutional investors own 81.54% of the company's stock.

Corteva Stock Performance

Shares of Corteva stock traded down $0.81 during trading on Wednesday, reaching $63.65. The company's stock had a trading volume of 2,379,875 shares, compared to its average volume of 3,651,365. Corteva, Inc. has a 52 week low of $50.01 and a 52 week high of $66.24. The business's 50-day moving average price is $60.58 and its 200-day moving average price is $58.67. The company has a quick ratio of 0.93, a current ratio of 1.45 and a debt-to-equity ratio of 0.08. The firm has a market cap of $43.75 billion, a PE ratio of 49.34, a P/E/G ratio of 1.68 and a beta of 0.78.

Corteva (NYSE:CTVA - Get Free Report) last posted its quarterly earnings data on Wednesday, February 5th. The company reported $0.32 earnings per share for the quarter, missing the consensus estimate of $0.34 by ($0.02). Corteva had a return on equity of 7.19% and a net margin of 5.36%. Equities analysts forecast that Corteva, Inc. will post 2.96 earnings per share for the current year.

Corteva announced that its board has authorized a stock buyback program on Tuesday, November 19th that permits the company to buyback $3.00 billion in shares. This buyback authorization permits the company to buy up to 7.5% of its shares through open market purchases. Shares buyback programs are usually a sign that the company's leadership believes its stock is undervalued.

Corteva Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 17th. Investors of record on Monday, March 3rd will be given a dividend of $0.17 per share. The ex-dividend date of this dividend is Monday, March 3rd. This represents a $0.68 annualized dividend and a yield of 1.07%. Corteva's dividend payout ratio is 52.71%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on CTVA shares. UBS Group lowered their target price on shares of Corteva from $74.00 to $73.00 and set a "buy" rating on the stock in a report on Friday, January 10th. Citigroup lifted their price objective on shares of Corteva from $69.00 to $74.00 and gave the stock a "buy" rating in a research report on Wednesday, January 29th. Bank of America lifted their price objective on shares of Corteva from $69.00 to $73.00 and gave the stock a "buy" rating in a research report on Tuesday, February 11th. Royal Bank of Canada lifted their price objective on shares of Corteva from $72.00 to $73.00 and gave the stock an "outperform" rating in a research report on Friday, February 7th. Finally, Oppenheimer lifted their price objective on shares of Corteva from $70.00 to $72.00 and gave the stock an "outperform" rating in a research report on Friday, February 7th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and thirteen have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $67.73.

Corteva Company Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.